Comparison of pathophysiological differences in TAFRO syndrome with or without lymphadenopathy-Reference-Cited by-同舟云学术

Comparison of pathophysiological differences in TAFRO syndrome with or without lymphadenopathy

Published:2024 Issue: Volume: Page:
ISSN:1346-4280
Container-title:Journal of Clinical and Experimental Hematopathology
language:en
Short-container-title:JCEH

Author:

Uchiyama Takayoshi¹,Yokoyama Aki¹,Kuroda Yuzu¹,Aoki Sadao¹

Affiliation:

1. Division of Hematology, Niigata University of Pharmacy and Medical and Life Sciences, Faculty of Medical Technology, Niigata City, Niigata, Japan

Publisher

Japanese Society for Lymphoreticular Tissue Research

Link

https://www.jstage.jst.go.jp/article/jslrt/advpub/0/advpub_24026/_pdf

Reference21 articles.

1. 1 Takai K, Nikkuni K, Shibuya H, Hashidate H. [Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly]. Rinsho Ketsueki. 2010; 51: 320-325.

2. 2 Kawabata H, Takai K, Kojima M et al. Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012). J Clin Exp Hematop. 2013; 53: 57-61.

3. 3 Masaki Y, Arita K, Sakai T et al. Castleman disease and TAFRO syndrome. Ann Hematol. 2022; 101: 485-490.

4. 4 Masaki Y, Kawabata H, Takai K et al. [Proposed diagnostic criteria, disease severity classification, and treatment strategy for a novel disorder; TAFRO syndrome]. Rinsho Ketsueki. 2016; 57: 2029-2037.

5. 5 Masaki Y, Kawabata H, Takai K et al. Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version. Int J Hematol. 2016; 103: 686-692.